可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 郭晓强,时兰春. 受磷蛋白与心力衰竭[J]. 心脏杂志, 2005, 17(5):487-489.
[2] Li SZ, Zang YM, Wang B, et al. Activation of reverse-mode NCX during metabolic inhibition pretreatment triggers the cardioprotection of preconditioning[J] . 心脏杂志, 2006, 18(1):23-27.
[3] 奚群英,祝宝华. 肌膜钙调节与心肌缺血预适应及心脏保护[J]. 心脏杂志, 2005, 17(12):154-156.
[4] Bers DM. Macromolecular complexes regulating cardiac ryanodine receptor function[J]. J Mol Cell Cardiol, 2004, 37(2):417-429.
[5] Bellinger AM, Mongillo M, Marks AR. Stressed out: the skeletal muscle ryanodine receptor as a target of stress[J]. J Clin Invest, 2008, 118(2):445-453.
[6] Samsó M, Shen X, Allen PD. Structural characterization of the RyR1-FKBP12 interaction[J]. J Mol Biol, 2006, 356(4):917-927.
[7] Aracena-Parks P, Goonasekera SA, Gilman CP, et al. Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1[J]. J Biol Chem, 2006, 281(52):40354-40368.
[8] Dulhunty AF, Beard NA, Pouliquin P, et al. Novel regulators of RyR Ca2+ release channels: insight into molecular changes in genetically-linked myopathies[J]. J Muscle Res Cell Motil, 2006, 27(5-7):351-365.
[9] Bellinger AM, Reiken S, Dura M, et al. Remodeling of ryanodine receptor complex causes “leaky” channels: a molecular mechanism for decreased exercise capacity[J]. Proc Natl Acad Sci USA, 2008, 105(6):2198-2202.